Journals / Medical Network Klinik Bilimler ve Doktor / 2005 / Cilt: 11 - Sayı: 1

Intrahepatic cholestasis: Report of two cases

Gebelikte intrahepatik kolestazı: İki olgu sunumu

Pages
105–107
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the present study fetal and maternal effects of intrahepatic cholestasis during the course of pregnancy was presented and the effectiveness of therapy was discussed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Intrahepatic cholestasis is generally encountered after the 30 gestational week of pregancy.
📊
Key Findings & Data:Maternal effects of disease are genarally not serious but fetal complications are more harmful.
💡
Conclusion & Impact:In the present study fetal and maternal effects of intrahepatic cholestasis during the course of pregnancy was presented and the effectiveness of therapy was discussed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Kolestaz · intrahepatik · Gebelik komplikasyonları

Abstract

Intrahepatic cholestasis is generally encountered after the 30 gestational week of pregancy. Maternal effects of disease are genarally not serious but fetal complications are more harmful. In the present study fetal and maternal effects of intrahepatic cholestasis during the course of pregnancy was presented and the effectiveness of therapy was discussed.

Özet

İntrahepatik kolestaz genellikle 30. gebelik haftasından sonra görülür. Maternal etkileri nispeten az olmasına rağmen fetal komplikasyonları çok ağır olabilir. Bu çalışmada gebelikte intrahepatik kolestaz saptanan iki olgunun fetal ve maternal komplikasyonları ayrıca verilen tedavinin etkinliği tartışılmıştır.

🔖

Cite This Article

AKERCAN, F., ULUKUŞ, M., TEREK, C., TURAN, Ö., ULUKUŞ, M., KARADADAŞ, N. (2005). Intrahepatic cholestasis: Report of two cases. Medical Network Klinik Bilimler ve Doktor, Cilt: 11 - Sayı: 1, 105–107. https://ajindex.com/articles/278354

References (9)

  1. Reyes H.Intrahepatic cholestasis.A puzzling disorder of pregnancy 'review'. J Gastroenterol Hepatol 1997; 12:211-6
  2. Asulyman OM, Ouzounian JG, Ames-Castro M, Goodwin TM. Intrahepatic cholestasis of pregnancy: Perinatal outcome ascociated with expectan management. Am J Obst Gynecol 1996; 175:957-60
  3. Lammert F, Marschall HU, Glantz A, Matem S. intrahepatic cholestasis of pregnancy: Molecular pathogenesis, diagnosis and managment. J Hepatol 2000; 33:1012-21
  4. Williamson C, Gorelik J, Eaton BM, de Switch M, Korchev Y. The bile acid taurocholate impairs rat cardiomyocyte function: a proposed mechanism for intra-uterin fetal death in obstetric cholestasis. Clin Sci (Lond) 2001; 100:363-9
  5. Palma J, Reyes H, Ribalta J, et al. Effects of ursodeoxy cholic acid in patients with intrahepatic cholestasis of pregnancy. Hepatology 1992; 15:1043-7
  6. Brites D, Rodriges CMP, Oliveira N, Cardoso MC, Graça LM. Correction of maternal serum bile acid profile during ursodeoxy cholic acid therapy in cholestasis of pregnancy. J Hepatol 1998; 28:91-8
  7. Jenkins JK, Booth by LA. Treatment of Itching Associated with pregnancy. Ann Pharmacother 2002; 36:1462-5
  8. Lammer F, Marchall HU, Matem S. Intrahepatic cholestasis of pregnancy: Curr Treat Options Gastroenterol 2003; 6:123-32
  9. Kretowicz E, Mclntyre HD. Intrahepatic cholestasis of pregnancy, worsening after dexametazone. Aust N Z J Obstet Gynaecol 1994; 34:211-3.